{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-000835","form_type":"8-K","ticker":"ALEC","cik":"0001653087","company_name":"Alector, Inc.","filed_at":"2022-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.631609+00:00","generated_at":"2026-06-27T10:40:58.821642+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Alector appoints Marc Grasso, M.D. as CFO; base salary $480K, stock option 450K shares","bullets":["Marc Grasso appointed CFO effective Feb 7, 2022; succeeds interim CFO Linda Rubinstein.","Annual base salary $480,000; eligible for performance bonus up to 40% of salary.","Received sign-on bonus of $103,000 and stock option for 450,000 shares vesting over 4 years.","Grasso previously CFO and CBO at Kura Oncology; brings investment banking background.","Rubinstein continues as Principal Financial Officer and Accounting Officer until Feb 25, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-000835","json":"https://secwatch.observer/filing/0000950170-22-000835.json","markdown":"https://secwatch.observer/filing/0000950170-22-000835.md","text":"https://secwatch.observer/filing/0000950170-22-000835.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1653087/000095017022000835/0000950170-22-000835-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1653087/000095017022000835/alec-20220207.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T10:40:58.821642+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"577db29e3a","claim":"Marc Grasso was appointed as Chief Financial Officer at Alector, Inc..","evidence_excerpt":"On February 7, 2022, Alector, Inc. (“Alector”) announced the appointment of Marc Grasso, M.D. as Alector’s Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1653087/000095017022000835/0000950170-22-000835-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"a8776fff32","claim":"Linda Rubinstein changed role as interim Chief Financial Officer at Alector, Inc..","evidence_excerpt":"Effective upon Dr. Grasso’s appointment on February 7, 2022, Ms. Linda Rubinstein will no longer serve as Alector’s interim Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1653087/000095017022000835/0000950170-22-000835-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"will no longer serve as"},{"label":"Role","value":"interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}